Analysts Reiterate Bullish Outlook on Eli Lilly and Company (LLY) Following Kelonia Acquisition
Summary
This is a reaffirmation of the firm’s initiation of coverage on the pharmaceutical company in February, when it noted Eli Lilly’s strong market share in obe...
Description
This is a reaffirmation of the firm’s initiation of coverage on the pharmaceutical company in February, when it noted Eli Lilly’s strong market share in obe...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source